Skip to main navigation Skip to search Skip to main content

Protocolo de descenso progresivo de la dosis de omalizumab en pacientes con asma alérgico corticodependiente; IgE libres como factor predictor

Project Details

StatusFinished
Effective start/end date1/01/12 → 31/12/14

Funding

  • Institute of Health Carlos III (ISCIII): €18,600.00